Despite the uniform pattern of CSF tau level changes in AD and DOC as compared to control, there was wide range of effect size among 11 articles under study in AD group (32.02–910.00 pg/mL) as compared to DOC group (−53.30–−518.00 pg/mL). The gene discussed is MAPT; the disease is Alzheimer disease.